Clinical Trial Update: BAY38-9456 - Supportive Trial for Spinal Injury [Phase 3]

View source ↗

Summary

Phase 3 trial of BAY38-9456 has completed as a supportive study in spinal cord injury. The study also involved erectile dysfunction and sexual dysfunction as co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Sexual Dysfunction
• Spinal Cord Injury

Drugs mentioned

• BAY38-9456

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction, Sexual Dysfunction | Phase 3 | Status: COMPLETED